24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

EMPAG Posters<br />

to optimize counseling service . We necessitate to analyze psychosocial<br />

features to fit counseling process to client personality and needs.<br />

To reach this goal, since 2004 we have evaluated needs for information,<br />

motivations and psychosocial characteristics <strong>of</strong> individuals asking<br />

for OGC because <strong>of</strong> their familial history <strong>of</strong> common cancers (breast,<br />

colon, thyroid, etc.). 110 counselees fulfilled a questionnaire before<br />

receiving OGC assessing: sociodemographic features, health locus <strong>of</strong><br />

control, monitoring/blunting, general self efficacy, motivations, emotional<br />

state and perceived risk . 76 were affected by cancer and 34<br />

were unaffected . Cancer risk was assessed either with genetic testing<br />

or with validated probabilistic models . Our results have showed that<br />

counselees have: no clinical psychological distress, high level <strong>of</strong> self<br />

efficacy but not a specific style <strong>of</strong> information seeking. They feel at high<br />

risk for cancer running in the family and they strongly want information<br />

about surveillance and prevention actions . Perceived risk is related to<br />

some psychological variables (coping and mood) and in unaffected<br />

people it is not related to cancer risk estimated . We can conclude that,<br />

individual seeking OGC have adaptive psychological resources that let<br />

them cope with familial cancer risk, and that evaluating psychological<br />

pr<strong>of</strong>ile has several implications into clinical practice, because psychological<br />

variables significantly influence risk perception.<br />

EP14.17<br />

triangulation <strong>of</strong> methods: a novel approach to investigating<br />

valued outcomes from using clinical genetics services<br />

M. McAllister 1 , K. Payne 2 , R. MacLeod 3 , D. Donnai 1 , L. Davies 2 ;<br />

1 Nowgen (A Centre for <strong>Genetics</strong> in Healthcare) & Medical <strong>Genetics</strong> Research<br />

Group, The University <strong>of</strong> Manchester, St Mary’s Hospital, Manchester, United<br />

Kingdom, 2 Nowgen (A Centre for <strong>Genetics</strong> in Healthcare) & Health Economics<br />

Research at Manchester, School <strong>of</strong> Community-based Medicine, The University<br />

<strong>of</strong> Manchester, Manchester, United Kingdom, 3 Medical <strong>Genetics</strong> Research<br />

Group, The University <strong>of</strong> Manchester, St Mary’s Hospital, Manchester, United<br />

Kingdom.<br />

The patient benefits from using clinical genetics services are hard to<br />

measure, and there is little consensus about appropriate outcome<br />

measures . This paper describes a programme <strong>of</strong> research that aimed<br />

to work towards a core set <strong>of</strong> outcome measures suitable for evaluating<br />

clinical genetics services . The approach involved 4 types <strong>of</strong> triangulation<br />

(method, investigator, discipline and data) . Three methods<br />

were used:<br />

(1) A systematic review <strong>of</strong> the literature identified the validated outcome<br />

measures (30 genetics-specific and 37 generic) used, or developed,<br />

to evaluate clinical genetics services .<br />

(2) A Delphi survey, aimed at identifying the degree <strong>of</strong> consensus<br />

about the relevance <strong>of</strong> existing outcome measures, was completed by<br />

a panel <strong>of</strong> 115 genetics clinicians and 72 patients <strong>of</strong> clinical genetics<br />

services . At least 75% <strong>of</strong> the panel agreed that the following outcome<br />

domains were useful: knowledge <strong>of</strong> the genetic condition, decisionmaking,<br />

perceived personal control, risk perception, satisfaction, meeting<br />

<strong>of</strong> expectations, coping, accuracy <strong>of</strong> diagnosis and quality <strong>of</strong> life .<br />

(3) Qualitative research (7 focus groups and 19 interviews) with patients<br />

<strong>of</strong> clinical genetics services, patient representatives and genetics<br />

health pr<strong>of</strong>essionals explored the outcomes valued by those stakeholders,<br />

and resulted in construction <strong>of</strong> a model <strong>of</strong> empowerment .<br />

Data triangulation clarified that the qualitative findings support many <strong>of</strong><br />

those from the Delphi, but identified some additional valued outcome<br />

domains that are not captured by available outcome measures, such<br />

as empowerment <strong>of</strong> other relatives and future generations . In conclusion,<br />

triangulation is a useful approach to investigate complex areas,<br />

such as outcome measurement .<br />

EP14.18<br />

Psychological evaluation <strong>of</strong> familial ovarian cancer screening<br />

(PsyFOcs): study update and baseline psychological data<br />

D. Lancastle 1 , K. Brain 1 , L. Fraser 2 , U. Menon 2 , A. Rosenthal 2 , I. Jacobs 2 , J.<br />

Mackay 2 , R. Iredale 1 , C. Phelps 1 , M. Rogers 1 , J. Austoker 3 , C. Bankhead 3 , A.<br />

Clements 3 , E. Watson 4 ;<br />

1 School <strong>of</strong> Medicine, Cardiff, United Kingdom, 2 Gynaecological Oncology, Institute<br />

for Women’s Health, UCL, London, United Kingdom, 3 Primary Care Research<br />

Education Group, Oxford, United Kingdom, 4 School <strong>of</strong> Health and Social<br />

Care, Oxford Brookes University, Oxford, United Kingdom.<br />

Purpose: The UK Familial Ovarian Cancer Screening Study (UK FO-<br />

CSS) aims to determine the effectiveness <strong>of</strong> ovarian cancer screen-<br />

ing for women at significantly increased risk <strong>of</strong> familial ovarian cancer.<br />

Phase 2 <strong>of</strong> the study involves annual transvaginal ultrasound scan<br />

(TVS) <strong>of</strong> the ovaries and 4-monthly CA125 blood tests with further<br />

tests prompted by rising CA125 or abnormal TVS .<br />

Method: PsyFOCS is a prospective cohort study which aims to determine<br />

the psychological effects <strong>of</strong> ovarian cancer screening . Around<br />

66% <strong>of</strong> women invited to PsyFOCS returned pre-screening baseline<br />

questionnaires .<br />

Results: Baseline analyses (N=991) showed that clinical levels <strong>of</strong><br />

depression and anxiety were reported by 2 .63% (n=26) and 14 .63%<br />

(n=145) <strong>of</strong> women respectively . However, over a third (n=369, 37 .24%)<br />

were moderately or highly distressed about their ovarian cancer risk<br />

according to the Impact <strong>of</strong> Event Scale (IES). There were no significant<br />

associations between IES distress and prior ovarian TVS (p= .50) or<br />

the number (p= .95) or reported stressfulness (p= .56) <strong>of</strong> repeat ovarian<br />

cancer screening in the past . However, highly distressed women were<br />

significantly younger than those reporting moderate or low distress<br />

(p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!